Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2520-8934
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions ; volume:4 ; number:1 ; day:11 ; month:1 ; year:2021 ; pages:1-9 ; date:12.2021
CVIR endovascular ; 4, Heft 1 (11.1.2021), 1-9, 12.2021
- Creator
-
Horie, Kazunori
Tanaka, Akiko
Suzuki, Kenji
Taguri, Masataka
Inoue, Naoto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s42155-021-00205-x
- URN
-
urn:nbn:de:101:1-2021030218070629635463
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Horie, Kazunori
- Tanaka, Akiko
- Suzuki, Kenji
- Taguri, Masataka
- Inoue, Naoto
- SpringerLink (Online service)
Other Objects (12)
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Drug-Coated Balloons for Restenosis Prophylaxis
In-stent restenosis in real world
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Drug-Coated Balloons for Restenosis Prophylaxis
In-stent restenosis in real world
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Drug-Coated Balloons for Restenosis Prophylaxis
In-stent restenosis in real world
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study